New Ancora assays for oncology produce precision results with MRD-grade sensitivity, delivering the full biological picture for every sample
Whether you're developing organoids, generating spheroids, evaluating organ-on-a-chip platforms, or implementing advanced 3D cell culture workflows, this free guide will help you compare leading 3D biology models, evaluate enabling technologies, and make informed decisions.
The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics (CDx) and laboratory infrastructure, supporting active programs with leading pharma partners
CLINICAL24 Ambassador Bamidele Farinre on workforce development, AI readiness, and creating opportunities for the next generation of laboratory professionals
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people
Take the survey and submit a guest editorial
Authentic voices. Shared expertise. A global conversation advancing the future of diagnostics.
New portfolio aims to support biosimilar developers accelerate the path to analytical similarity and improve process economics
Join the global clinical diagnostics conversation on LinkedIn
CLINICAL24 Ambassador Tahmina Hussain discusses why education, workforce development, and professional support must evolve alongside the future of laboratory diagnostics
CLINICAL24 Ambassador Daniel Monteiro explores the pressures facing the laboratory workforce and explains why accessible education, meaningful competency assessment, and critical thinking are essential to its future
Guest editorial written by Aida Noor, Biomedical Scientist, Founder of Biomedical Science & Beyond, CLINICAL24 Ambassador
Guest editorial by Maya Carlyle, Principal AI Engineer at the National Physical Laboratory (NPL)
Guest editorial by Frank Sandulu, award-winning Biomedical Scientist and CEO, Biomed Connect
Guest Editorial by Stephanie Ibbotson, Senior Director, Strategic Marketing and Market Access, Diasorin
Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them
Download this expert SelectScience guide to explore the technologies, strategies, and emerging trends helping researchers generate deeper insight, improve efficiency, and build more confident cell line development (CLD) workflows.
